|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
ADVANCED NEUROMODULATION SYSTEMS INC 6901 PRESTON ROAD PLANO, TX 75024 |
X | |||
SPAC Acquisition Corp. 103 FOULK ROAD SUITE 202 WILMINGTON, DE 19803 |
X |
/s/ F. ROBERT MERRILL III, Vice President, Chief Financial Officer and Treasurer on behalf of Advanced Neuromodulation Systems, Inc. | 02/22/2005 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | This amended Form 4 correctly reports the sale transactions as occurring on February 15, 2005, not February 14, 2005 as previously reported. |
(2) | The reported securities were originally purchased by Advanced Neuromodulation Systems, Inc. ("ANS") on August 12 and 13, 2004, and, effective as of February 4, 2005, ANS contributed these securities to its wholly-owned subsidary, SPAC Acquisition Corp. ("SPAC"). Therefore, SPAC is the direct beneicial owner, and ANS is the indirect beneficial owner, of the reported securities. |
Remarks: This amended Form 4 correctly indicates a joint filing by ANS and SPAC and corrects the Form 4 filed on February 16, 2005 to include SPAC as a reporting person with respect to the sale transactions reported therein. |